GRHL2 and ovarian cancer: Therefore, in ovarian cancer cells with intermediate phenotypes, GRHL2 overexpression resulted in partial MET from an intermediate mesenchymal towards an intermediate epithelial state, with the co-expression of E-cadherin and vimentin.